Optimal Predictor for 6-Mercaptopurine Intolerance in Chinese Children With Acute Lymphoblastic Leukemia: NUDT15, TPMT, or ITPA Genetic Variants?

BMC Cancer - United Kingdom
doi 10.1186/s12885-018-4398-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Allopurinol Reverses Mercaptopurine-Induced Hypoglycemia in Patients With Acute Lymphoblastic Leukemia

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2019English

Urolithiasis in Children With Acute Lymphoblastic Leukemia

Journal of Analytical Oncology
Cancer ResearchOncology
2013English

Leukemia-Associated Genetic Aberrations in Mesenchymal Stem Cells of Children With Acute Lymphoblastic Leukemia

Journal of Molecular Medicine
Molecular MedicineDrug DiscoveryGenetics
2010English

506. Highly Efficient Treatment of Ph+ Acute Lymphoblastic Leukemia With a DNA Vaccine and 6-Mercaptopurine in Mice

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2011English

TPMTandNUDT15genes Are Both Related to Mercaptopurine Intolerance in Acute Lymphoblastic Leukaemia Patients From Uruguay

British Journal of Haematology
Hematology
2017English

Genetic Variants in the Folate Pathway and Risk of Childhood Acute Lymphoblastic Leukemia

Cancer Causes and Control
Cancer ResearchOncology
2011English

Germline Genomic Variants Associated With Childhood Acute Lymphoblastic Leukemia

Nature Genetics
Genetics
2009English

Transient Hyperglycemia in Hispanic Children With Acute Lymphoblastic Leukemia

Pediatric Blood and Cancer
OncologyChild HealthHematologyPerinatologyMedicinePediatrics
2005English

The Impact of High-Dose Methotrexate on Intracellular 6-Mercaptopurine Disposition During Interval Therapy of Childhood Acute Lymphoblastic Leukemia

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy